Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer

1. Heymach, J.V.
2. Paz-Ares, L.
3. De Braud, F.
4. Sebastian, M.
5. Stewart, D.J.
6. Eberhardt, W.E.E.
7. Ranade, A.A.
8. Cohen, G.
9. Trigo, J.M.
10. Sandler, A.B.
11. Bonomi, P.D.
12. Herbst, R.S.
13. Krebs, A.D.
14. Vasselli, J.
15. Johnson, B.E.